University Hospital of Lyon-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University Hospital of Lyon - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013584
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University Hospital of Lyon (HCL) is a healthcare service provider that offers patient care and educational services. The hospital provides care, education, research and medical innovation, prevention and health training services. It provides human, technical and logistical resources for maternity department, oncology, transplantation, neuroscience, and molecular genetics. HCL carries out constant research and development and carries out several clinical trials. The hospital operates in the areas of cancer research, onco-haematology, infectious diseases, immunology, inflammation, nutrition, cardiovascular, neurology and transplantation. The hospital provides healthcare services to various age group patients. It operates cancer research and neurosciences research center and units. HCL is headquartered in Lyon, France.

University Hospital of Lyon – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University Hospital of Lyon, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
NeuroVive Pharma Extends Agreement with Hospices Civils de Lyon 10
NeuroVive Pharma Extends Agreement with Hospices Civils de Lyon for Pre-clinical R&D Programs 11
NeuroVive Pharma Enters into Agreement with Hospices Civils de Lyon 12
University Hospital of Lyon – Key Competitors 13
University Hospital of Lyon – Key Employees 14
University Hospital of Lyon – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
University Hospital of Lyon, Pharmaceuticals & Healthcare, Key Facts 2
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University Hospital of Lyon, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University Hospital of Lyon, Deals By Therapy Area, 2011 to YTD 2017 8
University Hospital of Lyon, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
NeuroVive Pharma Extends Agreement with Hospices Civils de Lyon 10
NeuroVive Pharma Extends Agreement with Hospices Civils de Lyon for Pre-clinical R&D Programs 11
NeuroVive Pharma Enters into Agreement with Hospices Civils de Lyon 12
University Hospital of Lyon, Key Competitors 13
University Hospital of Lyon, Key Employees 14

★海外企業調査レポート[University Hospital of Lyon-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marquard & Bahls AG:企業の戦略・SWOT・財務分析
    Marquard & Bahls AG - Strategy, SWOT and Corporate Finance Report Summary Marquard & Bahls AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • New Gold Inc:企業の戦略・SWOT・財務情報
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Yext, Inc. (YEXT):企業の財務・戦略的SWOT分析
    Yext, Inc. (YEXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UTair Aviation:企業の戦略・SWOT・財務情報
    UTair Aviation - Strategy, SWOT and Corporate Finance Report Summary UTair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hunter Engineering Co:企業の戦略的SWOT分析
    Hunter Engineering Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Memphasys Ltd (MEM)-製薬・医療分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a life science company that develops and sells pre-cast electrophoresis gels, separations equipment and consumables, analytical software, and other biological products. The company offers gels which include tris glycine, and tris hepe …
  • CaroGen Corp-製薬・医療分野:企業M&A・提携分析
    Summary CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle th …
  • ANI Technologies Pvt Ltd:企業の戦略的SWOT分析
    ANI Technologies Pvt Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Repsol, S.A.:企業の戦略・SWOT・財務分析
    Repsol, S.A. - Strategy, SWOT and Corporate Finance Report Summary Repsol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tomra Systems ASA (TOM):企業の財務・戦略的SWOT分析
    Summary Tomra Systems ASA (Tomra Systems) is a logistics company that offers collection and sorting solutions. The company offers products such as managing tools, process analytics equipment, food processing lines, sorting systems, raw materials, raw material sorting equipment, and other specialty p …
  • VION N.V.:企業の戦略・SWOT・財務分析
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Monsanto Company (MON)-製薬・医療分野:企業M&A・提携分析
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. Monsanto also provides other …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Xencor, Inc.:企業のM&A・事業提携・投資動向
    Xencor, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Xencor, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Westell Technologies Inc (WSTL):企業の財務・戦略的SWOT分析
    Summary Westell Technologies Inc (Westell) is a communication service company that provides wireless infrastructure solutions. The company offers in-building wireless, intelligent site management and communication network solutions. The company’sin-building wireless include antennas, distributed ant …
  • KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers cu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆